• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抗孕激素甾体的合成。

Synthesis of antiprogestational steroids.

作者信息

Wiechert R, Neef G

机构信息

Research Laboratories, Schering AG, Berlin, F.R.G.

出版信息

J Steroid Biochem. 1987;27(4-6):851-8. doi: 10.1016/0022-4731(87)90159-2.

DOI:10.1016/0022-4731(87)90159-2
PMID:3320563
Abstract

The discovery of the first competitive progesterone antagonist RU 38,486 has initiated an intense search for more potent and more selective anti-progestins. Among several hundreds of compounds under preliminary investigation, biological characterization is most advanced for derivatives RU 38,486, ZK 98,734 and ZK 98,299. These compounds do not only differ in relative potency, but are clearly distinguished by their different behaviour in various animal models. Emphasis is laid on the synthetic problems associated with chemical operations in a sterically crowded environment as represented by structures RU 38,486 and ZK 98,299.

摘要

首个竞争性孕激素拮抗剂RU 38,486的发现引发了对更强效、更具选择性的抗孕激素的深入探索。在数百种处于初步研究阶段的化合物中,RU 38,486、ZK 98,734和ZK 98,299衍生物的生物学特性研究最为深入。这些化合物不仅在相对效力上有所不同,而且在各种动物模型中的表现也明显不同。重点在于与RU 38,486和ZK 98,299结构所代表的空间拥挤环境中的化学操作相关的合成问题。

相似文献

1
Synthesis of antiprogestational steroids.抗孕激素甾体的合成。
J Steroid Biochem. 1987;27(4-6):851-8. doi: 10.1016/0022-4731(87)90159-2.
2
Modulatory actions of the new antiprogestins ZK 98.299 and ZK 98.734 and of RU 486 on luteinizing hormone secretion and progesterone effects in pituitary gonadotrophs.新型抗孕激素ZK 98.299、ZK 98.734及RU 486对垂体促性腺细胞中促黄体生成素分泌及孕酮作用的调节作用
J Steroid Biochem. 1990 Aug 14;36(5):431-7. doi: 10.1016/0022-4731(90)90084-6.
3
Luteolytic action of two antiprogestational agents (RU-38486 and ZK-98734) in the rat.两种抗孕激素药物(RU-38486和ZK-98734)对大鼠的溶黄体作用
J Reprod Fertil. 1988 May;83(1):73-83. doi: 10.1530/jrf.0.0830073.
4
Clinical uses of antiprogestogens.抗孕激素的临床应用。
Hum Reprod Update. 1995 Jan;1(1):19-34. doi: 10.1093/humupd/1.1.19.
5
Relative binding affinity of antiprogestins ZK 98.299 and ZK 98.734 for progesterone receptors in the endometrium and myometrium of bonnet monkeys.抗孕激素ZK 98.299和ZK 98.734对帽猴子宫内膜和子宫肌层中孕激素受体的相对结合亲和力。
J Recept Res. 1987;7(6):903-20. doi: 10.3109/10799898709054569.
6
The effect of the antiprogestins RU 486 and ZK 98734 on the synthesis and metabolism of prostaglandins F2 alpha and E2 in separated cells from early human decidua.
J Clin Endocrinol Metab. 1987 Sep;65(3):527-34. doi: 10.1210/jcem-65-3-527.
7
Pharmacological properties of a new selective antiprogestagen: Org 33628.一种新型选择性抗孕激素Org 33628的药理特性
Ann N Y Acad Sci. 1995 Jun 12;761:192-201. doi: 10.1111/j.1749-6632.1995.tb31379.x.
8
Antiprogestins and iatrogenic glucocorticoid resistance.抗孕激素与医源性糖皮质激素抵抗
Life Sci. 1997;60(9):617-24. doi: 10.1016/s0024-3205(96)00698-4.
9
Pharmacology of two new very selective antiprogestagens: Org 31710 and Org 31806.两种新型高选择性抗孕激素Org 31710和Org 31806的药理学
Hum Reprod. 1994 Jun;9 Suppl 1:47-52. doi: 10.1093/humrep/9.suppl_1.47.
10
Termination of early pregnancy with ZK 98,734: pharmacokinetic behaviour and clinical effect.
Hum Reprod. 1994 Jan;9(1):57-63. doi: 10.1093/oxfordjournals.humrep.a138320.

引用本文的文献

1
Discovery of Vilaprisan (BAY 1002670): A Highly Potent and Selective Progesterone Receptor Modulator Optimized for Gynecologic Therapies.Vilaprisan(BAY 1002670)的发现:一种用于妇科治疗的高活性和选择性孕激素受体调节剂。
ChemMedChem. 2018 Nov 6;13(21):2271-2280. doi: 10.1002/cmdc.201800487.
2
Antiprogestin pharmacodynamics, pharmacokinetics, and metabolism: implications for their long-term use.抗孕激素的药效学、药代动力学及代谢:长期使用的影响
J Pharmacokinet Biopharm. 1997 Dec;25(6):647-72. doi: 10.1023/a:1025725716343.
3
Promotion of agonist activity of antiandrogens by the androgen receptor coactivator, ARA70, in human prostate cancer DU145 cells.
雄激素受体共激活因子ARA70在人前列腺癌DU145细胞中促进抗雄激素的激动剂活性。
Proc Natl Acad Sci U S A. 1998 Jun 23;95(13):7379-84. doi: 10.1073/pnas.95.13.7379.
4
In vivo evidence against the existence of antiprogestins disrupting receptor binding to DNA.体内证据表明不存在干扰受体与DNA结合的抗孕激素。
Proc Natl Acad Sci U S A. 1993 May 15;90(10):4421-5. doi: 10.1073/pnas.90.10.4421.
5
Steroid receptor domain conformations and hormone antagonism.类固醇受体结构域构象与激素拮抗作用。
Naturwissenschaften. 1994 Mar;81(3):115-22. doi: 10.1007/BF01131766.